None listed
Conditions
Interventions
None listed
Sponsors
Yonsei University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Biopsy proven following glomerular diseases irrespect of primary or secondary 1) Focal segmental glomerulosclerosis, FSGS 2) Membranous glomerulonephritis, MN 3) Membranoproliferative glomerulonephritis, MPGN 4) Fibrillary glomerulonephritis 5) IgM nephropathy 6) C3 glomerulonephritis 7) Anti-glomerular basement membrane glomerulonephritis 8) Lupus nephritis 9) ANCA associated glomerulonephritis 10) Alport syndrome 11) Fabry disease 12) Other glomerular disease other than IgA nephropathy nor dabetic nephropathy 2. Patient who performed renal biopsy within 6 months at screening visit 3. Adult over 19 years old
Exclusion criteria
Exclusion criteria: 1.Under renal replacement therapy (hemodialysis, peritoneal dialysis, and kidney transplantation) on screening 2.Pathologically confirmed diabetic nephropathy 3. Paphologically confirmed IgA nephropathy 4.Under immunsuppresition therapy on screening
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Loss of 40% eGFR from baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Mortality;Complete remission of glomerular disease;Doubling of serum creatinine compared to baseline level;Incidence of cardiovascular disease;incident end-stage renal disease that defined as initiation of hemodialysis or peritoneal dialysis or kidney transplantation | — |
Countries
Korea, Republic of
Contacts
Public ContactYoung Su Joo
Yonsei University Health System, Severance Hospital
Outcome results
None listed